Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty Midcap Select
Nifty Midcap Select Performance
Day's Range
Low
₹14,357.10
High
₹14,522.80
52 Week Range
Low
₹12,046.20
High
₹14,590.60
| Previous Close | ₹14,369.60 |
|---|---|
| Day's Range | ₹14,357.10 - ₹14,522.80 |
| Open | ₹14,480.85 |
| 52 Week Range | ₹12,046.20 - ₹14,590.60 |
| Volume | 13,58,01,480 |
Nifty Midcap Select Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Bharat Heavy Electricals Ltd. | 407.95 |  -0.45 (-0.11%) |
Capital Goods |
| Hindustan Petroleum Corporation Ltd. | 388.80 |  6.05 (1.58%) |
Crude Oil |
| Hero MotoCorp Ltd. | 4968.00 | 0.00 (0.00%) |
Automobile & Ancillaries |
| Lupin Ltd. | 2282.90 | -2.60 (-0.11%) |
Healthcare |
| Ashok Leyland Ltd. | 155.30 | 1.69 (1.10%) |
Automobile & Ancillaries |
| Bharat Forge Ltd. | 1903.80 | 15.60 (0.83%) |
Automobile & Ancillaries |
| SRF Ltd. | 2618.00 | 4.70 (0.18%) |
Chemicals |
| Aurobindo Pharma Ltd. | 1540.60 | 23.10 (1.52%) |
Healthcare |
| Marico Ltd. | 832.00 | -6.45 (-0.77%) |
FMCG |
| IndusInd Bank Ltd. | 898.15 | 1.00 (0.11%) |
Bank |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23663.8 | 26373.20 | 22182.55 |
| Nifty IT | 29030.7 | 40301.40 | 27078.00 |
| Nifty Next 50 | 69660.35 | 72037.60 | 59896.10 |
| NIFTY50 USD Index | 8515.8 | 10443.40 | 8132.40 |
| Nifty Bank | 53479.2 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 61415.15 | 62113.85 | 52032.85 |
| Nifty 500 | 22620.75 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17487.35 | 17686.30 | 14804.55 |
| Nifty 100 | 24614.25 | 26975.15 | 22720.45 |
| Nifty FMCG | 50322.1 | 58485.05 | 45334.15 |
Latest News
Yes Bank informs about change in SMP
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Yes Bank has informed about following the change in SMP of the Bank. Ajay Rajan, Country Head - Transaction Banking, Government, MNC & New Economy Business, and IBU, had tendered his resignation on account of better profile on April 09, 2026. The Bank will relieve Ajay Rajan from his duties on May 31, 2026. Accordingly, the above information as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure A. The copy of letter of resignation as given by Ajay Rajan is also enclosed. The weblink of BSE and National Stock Exchange of India providing the above information is being hosted on the Bank’s website www.yes.bank.in pursuant to Listing Regulations, as amended.
The above information is a part of company’s filings submitted to BSE.
AU Small Finance Bank informs about press release
AU Small Finance that the Bank has collaborated with Intellect Design Arena, a global leader in AI-First, enterprise-grade financial technology, adopting its Purple Fabric platform, the world’s first Open Business Impact AI platform. Through this collaboration, the Bank aims to accelerate its journey towards becoming an AI-first bank and build a scalable, technology-led banking franchise powered by enterprise-wide intelligence. This engagement marks a defining milestone in the adoption of enterprise AI in Indian banking, bringing together the Bank’s AI-first ambition and Intellect’s AI-first banking capabilities to deliver enterprise-wide intelligence at scale. The press release in this regard is enclosed. In compliance with Regulation 46 of the Listing Regulations, the information is being hosted on the Bank's website at https://www.au.bank.in/stock-exchange-disclosures.
The above information is a part of company’s filings submitted to BSE.
One 97 Communications informs about press release
Aurobindo Pharma informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that: CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, announced that the Central Drugs Standard Control Organization (CDSCO) has granted Marketing Authorisation under Form CT 23 for Bevqolva®, a bevacizumab biosimilar indicated for metastatic carcinoma of the colon or rectum. The authorisation permits manufacture at CuraTeQ’s facility in Hyderabad and marketing of Bevqolva® in 100 mg/4mL and 400 mg/16 mL vial presentations.
The above information is a part of company’s filings submitted to BSE.
Lupin informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of MIDCPNIFTY index is ₹14385.8 as of 2026-05-21.
The total volume of MIDCPNIFTY index is 135801480.00 as of 2026-05-21.
The percentage change in value of MIDCPNIFTY index is 0.11% as of 2026-05-21.
The absolute increase in MIDCPNIFTY index value since the previous trading day is ₹16.2 as of 2026-05-21.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
